Hester Biosciences has informed that the Board of Directors of the Company at its meeting held on October 20, 2016, has declared an interim dividend of 30 percent, i.e. Rs 3 per equity share on the face value of Rs 10 per share, for the financial year 2016-17. The Board of Directors has also considered the revision in Remuneration and Re-appointment of Rajiv Gandhi as a CEO & Managing Director subject to approval of Shareholders and Central Government, if any.
The above information is a part of company’s filings submitted to BSE.
